DDIAX
Price
$16.13
Change
-$0.02 (-0.12%)
Updated
Oct 6 closing price
Net Assets
847.45M
RLBGX
Price
$39.06
Change
+$0.07 (+0.18%)
Updated
Oct 6 closing price
Net Assets
265.73B
Interact to see
Advertisement

DDIAX vs RLBGX

Header iconDDIAX vs RLBGX Comparison
Open Charts DDIAX vs RLBGXBanner chart's image
Macquarie Wealth Builder A
Price$16.13
Change-$0.02 (-0.12%)
VolumeN/A
Net Assets847.45M
American Funds American Balanced R6
Price$39.06
Change+$0.07 (+0.18%)
VolumeN/A
Net Assets265.73B
DDIAX vs RLBGX Comparison Chart in %
View a ticker or compare two or three
VS
DDIAX vs. RLBGX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDIAX is a Buy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 266B vs. DDIAX (847M). RLBGX pays higher dividends than DDIAX: RLBGX (2.05) vs DDIAX (1.50). DDIAX was incepted earlier than RLBGX: DDIAX (29 years) vs RLBGX (16 years). DDIAX (1.09) is less costly to investors than RLBGX (0.25). DDIAX is a more actively managed with annual turnover of: 66.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than DDIAX: RLBGX (250) vs DDIAX (1000). RLBGX annual gain was more profitable for investors over the last year : 10.01 vs. DDIAX (5.26). RLBGX return over 5 years is better than : 45.71 vs. DDIAX (33.57).
DDIAXRLBGXDDIAX / RLBGX
Total Expense Ratio1.060.25424%
Annual Report Gross Expense Ratio1.090.25436%
Fund Existence29 years16 years-
Gain YTD11.07715.01074%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets847M266B0%
Annual Yield % from dividends1.502.0573%
Returns for 1 year5.2610.0153%
Returns for 3 years29.1852.9955%
Returns for 5 years33.5745.7173%
Returns for 10 years43.7680.8854%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKE18.140.68
+3.89%
Skeena Resources Limited
ISRL13.000.30
+2.39%
Israel Acquisitions Corp
PACB1.520.03
+2.01%
Pacific Biosciences of California
AKAM78.440.88
+1.13%
Akamai Technologies
NIVF1.75-0.09
-4.89%
NewGenIvf Group Limited